StockData
Dolby Laboratories, Inc. logo

Dolby Laboratories, Inc. (DLB) stock

DLBNYSEPatent Owners & LessorsFiscal year ends September 27
Financials through Q4 FY2026, quarter ended Sep 25, 2026Last filing: 10-K on Nov 17, 2026Score 21/3016% below fair value
$58.82−2.34 (-3.83%)

Close on Nov 17, 2026Market cap $5.51BP/E 21.8Yield 2.45%

Dolby Laboratories operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Dolby Laboratories's operating cash flow for the twelve months ending Sep 25, 2026 was $399.55M, down 15.4% year over year. For fiscal 2026 it was $399.55M, down 15.4% from the year before. Over ten years it grew 1.0% a year on average. The highest annual figure on record is $472.20M in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2026Sep 25, 2026$399.55M-15.4%
FY2025Sep 26, 2025$472.20M+44.3%
FY2024Sep 27, 2024$327.25M-10.9%
FY2023Sep 29, 2023$367.08M+15.2%
FY2022Sep 30, 2022$318.58M-28.9%
FY2021Sep 24, 2021$447.75M+30.2%
FY2020Sep 25, 2020$343.85M+4.9%
FY2019Sep 27, 2019$327.67M-7.0%
FY2018Sep 28, 2018$352.20M-6.8%
FY2017Sep 29, 2017$377.79M+4.9%
FY2016Sep 30, 2016$360.06M+16.4%
FY2015Sep 25, 2015$309.38M-14.4%
FY2014Sep 26, 2014$361.55M+30.8%
FY2013Sep 27, 2013$276.50M-29.1%
FY2012Sep 28, 2012$389.92M-3.4%
FY2011Sep 30, 2011$403.69M+23.3%
FY2010Sep 24, 2010$327.30M+19.8%
FY2009Sep 25, 2009$273.23M+3.3%
FY2008Sep 26, 2008$264.47M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ3 2026Sep 25, 2026$84.78M-31.0%
Q3 FY2026CQ2 2026Jun 26, 2026$167.46M+147.4%
Q2 FY2026CQ1 2026Mar 27, 2026$92.51M-47.1%
Q1 FY2026CQ4 2025Dec 26, 2025$54.80M-48.7%
Q4 FY2025CQ3 2025Sep 26, 2025$122.83M+5.7%
Q3 FY2025CQ2 2025Jun 27, 2025$67.69M+218.3%
Q2 FY2025CQ1 2025Mar 28, 2025$174.90M-3.6%
Q1 FY2025CQ4 2024Dec 27, 2024$106.78M+1169.8%
Q4 FY2024CQ3 2024Sep 27, 2024$116.17M+36.6%
Q3 FY2024CQ2 2024Jun 28, 2024$21.26M-82.4%
Q2 FY2024CQ1 2024Mar 29, 2024$181.41M+73.5%
Q1 FY2024CQ4 2023Dec 29, 2023$8.41M-85.1%
Q4 FY2023CQ3 2023Sep 29, 2023$85.02M+65.7%
Q3 FY2023CQ2 2023Jun 30, 2023$121.13M-29.8%
Q2 FY2023CQ1 2023Mar 31, 2023$104.54M+65.9%
Q1 FY2023CQ4 2022Dec 30, 2022$56.40M+78.1%
Q4 FY2022CQ3 2022Sep 30, 2022$51.31M-53.3%
Q3 FY2022CQ2 2022Jul 1, 2022$172.61M+0.1%
Q2 FY2022CQ1 2022Apr 1, 2022$63.00M-24.5%
Q1 FY2022CQ4 2021Dec 31, 2021$31.66M-61.5%
Q4 FY2021CQ3 2021Sep 24, 2021$109.77M-2.6%
Q3 FY2021CQ2 2021Jun 25, 2021$172.35M+28.3%
Q2 FY2021CQ1 2021Mar 26, 2021$83.47M+27.0%
Q1 FY2021CQ4 2020Dec 25, 2020$82.16M+163.7%
Q4 FY2020CQ3 2020Sep 25, 2020$112.66M-13.7%
Q3 FY2020CQ2 2020Jun 26, 2020$134.29M+47.0%
Q2 FY2020CQ1 2020Mar 27, 2020$65.74M+34.5%
Q1 FY2020CQ4 2019Dec 27, 2019$31.16M-45.3%
Q4 FY2019CQ3 2019Sep 27, 2019$130.48M+16.8%
Q3 FY2019CQ2 2019Jun 28, 2019$91.35M-35.9%
Q2 FY2019CQ1 2019Mar 29, 2019$48.89M-39.6%
Q1 FY2019CQ4 2018Dec 28, 2018$56.95M+232.1%
Q4 FY2018CQ3 2018Sep 28, 2018$111.73M+38.9%
Q3 FY2018CQ2 2018Jun 29, 2018$142.43M+3.2%
Q2 FY2018CQ1 2018Mar 30, 2018$80.89M-8.7%
Q1 FY2018CQ4 2017Dec 29, 2017$17.15M-75.8%
Q4 FY2017CQ3 2017Sep 29, 2017$80.43M–
Q3 FY2017CQ2 2017Jun 30, 2017$138.04M–
Q2 FY2017CQ1 2017Mar 31, 2017$88.61M–
Q1 FY2017CQ4 2016Dec 30, 2016$70.72M–

More Dolby Laboratories figures

See a number that looks wrong?